These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 649312)

  • 1. Serum gastrin and the irritable bowel syndrome.
    Geoghegan J; Fielding JF
    Ir J Med Sci; 1978 Apr; 147(4):156. PubMed ID: 649312
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum motilin in gastrointestinal diseases.
    Ohe K; Sumii K; Sano K; Kishimoto S; Miyoshi A
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():167-72. PubMed ID: 7227318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basal gastrin secretion in patients with ulcerative colitis and functional disorders of the large intestine].
    Rumiantsev VG; Kabanov AV; Bulgakov SA
    Klin Med (Mosk); 1988 May; 66(5):104-6. PubMed ID: 3419086
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin concentrations in functional bowel disorders.
    Preston DM; Adrian TE; Christofides ND; Lennard-Jones JE; Bloom SR
    Gut; 1985 Oct; 26(10):1059-64. PubMed ID: 4054704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma substance P in the irritable bowel syndrome.
    McAllister C; Corbally N; Fielding JF
    Ir J Med Sci; 1985 Nov; 154(11):431-2. PubMed ID: 2419275
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatostatin and irritable bowel syndrome.
    Binimelis J; Webb SM; Monés J
    Lancet; 1987 Dec; 2(8574):1533. PubMed ID: 2892099
    [No Abstract]   [Full Text] [Related]  

  • 7. Short report: plasma somatostatin concentrations in the irritable bowel syndrome.
    O'Donnell LJ; Davidson K; Cameron D; Wass JA; Farthing MJ
    Aliment Pharmacol Ther; 1991 Dec; 5(6):659-63. PubMed ID: 1685924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the blood zinc in the irritable bowel syndrome: a preliminary study].
    Cavallo G; De Magistris R; Miluccio V; Iannuzzi R
    Minerva Dietol Gastroenterol; 1990; 36(2):77-81. PubMed ID: 2247262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease.
    Kruis W; Thieme C; Weinzierl M; Schüssler P; Holl J; Paulus W
    Gastroenterology; 1984 Jul; 87(1):1-7. PubMed ID: 6724251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The irritable bowel syndrome. Part III: hormonal influences.
    Harvey RF
    Clin Gastroenterol; 1977 Sep; 6(3):631-41. PubMed ID: 923141
    [No Abstract]   [Full Text] [Related]  

  • 11. Subclinical protein malnutrition in irritable bowel syndrome: assessment by retinol-binding protein (RBP) and thyroxine-binding pre-albumin (TBPA).
    Maudgal DP; Ang LT; Maxwell JD
    Hum Nutr Clin Nutr; 1983 Jan; 37(1):37-41. PubMed ID: 6404857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology.
    Maxton DG; Morris J; Whorwell PJ
    Gut; 1991 Jul; 32(7):784-6. PubMed ID: 1855685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cholesterol, cholesterol precursors and plant sterols in different inflammatory bowel diseases.
    Hakala K; Vuoristo M; Miettinen TA
    Digestion; 1996; 57(2):83-9. PubMed ID: 8786005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian variations of blood gastrin under enteral and/or parenteral nutrition in a case of short bowel syndrome.
    Salmon R; Accary JP; Dubrasquet M; Descorps-Declere A; Reinberg A
    Chronobiologia; 1982; 9(3):267-71. PubMed ID: 6816534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunochemical quantitation of sulfated and non-sulfated gastrins in serum.
    Andersen BN; De Magistris L; Rehfeld JF
    Clin Chim Acta; 1983 Jan; 127(1):29-39. PubMed ID: 6825308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum gastrin level in patients with colorectal adenoma or carcinoma].
    Imdahl A; Michalski Y; Eggstein S; Strik M; Farthmann EH
    Zentralbl Chir; 1992; 117(8):439-43. PubMed ID: 1414056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.
    Steadman CJ; Talley NJ; Phillips SF; Zinsmeister AR
    Mayo Clin Proc; 1992 Aug; 67(8):732-8. PubMed ID: 1434911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum gastrin is not higher in subjects with colonic neoplasia.
    Kikendall JW; Glass AR; Sobin LH; Bowen PE
    Am J Gastroenterol; 1992 Oct; 87(10):1394-7. PubMed ID: 1415093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Motility of the sigmoid in irritable bowel syndrome and colonic diverticulosis].
    Ritsema GH; Thijn CJ; Smout AJ
    Ned Tijdschr Geneeskd; 1990 Jul; 134(29):1398-401. PubMed ID: 2374631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post prandial changes in colonic motility related to serum gastrin levels.
    Kirwan WO; Smith AN
    Scand J Gastroenterol; 1976; 11(2):145-9. PubMed ID: 1265433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.